April 2012 Volume 19 Issue 2 1 9 2 European Journal of Volume 19 Issue 2 Pages 65–274 Hospital EUROPEAN JOURNAL OF HOSPITAL PHARMACY April 2012 Pharmacy SCIENCE AND PRACTICE © Health Head Images / www.fotosearch.com IN THIS ISSUE EAHP 2012 Congress preview Special Patient Groups Hospital Pharmacists creating standards of care Country Focus: Italy SIFO’s Young pharmacist group Growing pains in hospital pharmacy training Career perspectives for young pharmacists Special section All congress abstracts ejhp.bmj.com CCover_EJHPover_EJHP ((19_02)_OFC.indd19_02)_OFC.indd 1 22/28/2012/28/2012 99:33:29:33:29 PPMM Contents Volume 19 Issue 2 | EJHP April 2012 Editorial Country focus: Italy 65 Special patients, specialised care 73 The young pharmacists (SIFO) 75 The role of the hospital pharmacist in chemical and biological risk management: EAHP congress previews disinfectants as an example 67 European Study for Neonatal Excipient Exposure (ESNEE) Abstracts from the 2012 EAHP 68 Clinical challenges on how to optimise the Congress use of drugs beyond the label 77 Table of contents 69 Better medicines for children 78 General information 70 Changes in development and evaluation 79 Call for abstracts – 2013 Paris of new cancer drugs: what is needed to 80 Poster award nominee oral presentations guide practice? 85 Abstracts 71 Focus on genetic screening by hospital pharmacists 263 Author index 000_EJHP0_EJHP TTOCOC & EEdd bboardoard ((19_02).indd19_02).indd 1 22/28/2012/28/2012 77:39:04:39:04 PPMM EJHP: Science and Practice The offi cial journal of the European The European Journal of Hospital Pharmacy: Association of Hospital Pharmacists (EAHP) Science and Practice offers a high-quality, peer- Editor in Chief Arnold G. Vulto (The Netherlands) reviewed platform for the publication of practical [email protected] Editors and innovative research and aims to strengthen the V'lain Fenton-May (UK) [email protected] profi le and professional status of European hospital Per Hartvig Honoré (Denmark) [email protected] pharmacists Associate Editors Nicoletta Ambrogi (Italy) International Advisory Board Members [email protected] Contact Details Jean-Daniel Hecq (Belgium) [email protected] Mike Allwood (UK) Gregory L Kearns (USA) Editorial Offi ce Ana Herranz (Spain) Jos Beijnen (Netherlands) Hans-Peter Lipp (Germany) EJHP Science and Practice Editorial Offi ce, [email protected] Jo-Anne Brien (Australia) Howard McLeod (USA) BMA House, Tavistock Square, London, Catherine Mooney (UK) WC1H 9JR, UK [email protected] Moses S S Chow (USA) Mette Rasmussen (Denmark) T: +44 (0)20 7383 6235 Stefan Mühlebach (Switzerland) Lona Christrup (Denmark) Frans F H Rutten (Netherlands) F: +44 (0)20 7383 6787/6668 [email protected] George Dranitaris (Canada) Lene Sørensen (Denmark) E: [email protected] Ute Spöhrer (Germany) Toine Egberts (Netherlands) Larry Trissel (USA) [email protected] Permissions Juraj Sykora (Slovakia) Mirjana Gasperlin (Slovenia) John Urquhart (USA) http://journals.bmj.com/misc/permissions.dtl [email protected] Nick Holford (New Zealand) Helmut Viernstein (Austria) Production Editor Jean Vigneron (France) Robert Janknegt (Netherlands) Vesna Vrca-Bacic (Croatia) [email protected] [email protected] Disclaimer Supplement Enquiries While every effort is made by publishers T: +44 (0)20 7383 6795 and editorial board to see that no F: +44 (0)20 7554 6668 inaccurate or misleading data, opinions, E: [email protected] or statements appear in this Journal, Guidelines for Authors and Reviewers they wish to make it clear that the data Subscriptions and opinions appearing in the articles and Full instructions are available online at http://ejhp.bmj. T: +44 (0)20 7383 6270 advertisements herein are the responsibility com/site/about/guidelines.xhtml. Articles must be F: +44 (0)20 7383 6402 of the contributor or advertiser concerned. submitted electronically http://mc.manuscriptcentral. E: [email protected] Accordingly, the publishers and the com/ejhpharm. Authors retain copyright the European Association of Hospital Display Advertising Sales Pharmacists (EAHP), the editorial but are required to grant EJHP an exclusive licence Nick Gray (Sales Manager) committee and their respective to publish http://group.bmj.com/products/journals/ T: +44 (0)20 7383 6386 employees, offi cers and agents, accept no instructions-for-authors/licence-forms F: +44 (0)20 7383 6556 liability whatsoever for the consequences E: [email protected] of any such inaccurate or misleading data, http://group.bmj.com/group/advertising opinion or statement. While every effort is made to ensure that drug doses and Online Advertising Sales other quantities are presented accu rately, Subscription information Marc Clifford (Sales Manager) readers are advised that new methods T: +44 (0) 20 7383 6161 and techniques involving drug usage, EJHP: Science and Practice is published bimonthly F: +44 (0) 20 7383 6556 described within this Journal, should only E: [email protected] be followed in conjunction with the drug (subscribers receive all supplements) http://group.bmj.com/group/advertising manu facturer’s own published literature. Copyright: © 2012 The European Institutional Rates Personal Rates 2012 Author Reprints Association of Hospital Pharmacists 2012 Reprint Administrator (EAHP). All rights reserved; no part of this Print (includes online access T: +44 (0)20 7383 6305 publication may be reproduced, stored in a Print and online at no extra cost) F: +44 (0)20 7554 6185 retrieval system or transmitted in any form £165; ¤190; $265 E: [email protected] or by any means, electronic, mechanical, £485; ¤550; $782 (small) photocopying, recording or otherwise Online only £590; ¤670; $952 (medium) Commercial Reprints without prior permission. £145; ¤165; $230 (except USA & Canada) The European Journal of Hospital £660; ¤750; $1064 (large) Nadia Gurney-Randall Pharmacy: Science and Practice (EJHP Online only T: +44 (0)20 8445 5825 Science and Practice) is published £420; ¤480; $675 (small) F: +44 (0)20 8445 5870 bimonthly by BMJ Publishing Group Ltd, M: 07866 262344 typeset by Newgen and printed in the UK £530; ¤600; $855 (medium) E: [email protected] on acid-free paper from sustainable forests £600; ¤680; $968 (large) by Latimer Trend & Co Ltd, Plymouth, UK. Commercial Reprints (USA & Canada) The European Journal of Hospital Marsha Fogler Pharmacy: Science and Practice (EJHP T: +1 800 482 1450 (toll free in the USA) Science and Practice) (ISSN No: ISSN 2047-9956 (print), 2047-9964 (online) T: +1 856 489 4446 (outside the USA) 2047-9956) is distributed in the USA F: +1 856 489 4449 by Air Business Ltd. Periodicals postage Personal print or online only and institutional print subscriptions may E: [email protected] paid at Jamaica NY 11431. POSTMASTER: be purchased online at http://group.bmj.com/group/subs-sales/ send address changes to The European subscriptions (payment by Mastercard/Visa only). Journal of Hospital Pharmacy: Science and Residents of some EC countries must pay VAT; for details, call us or visit Practice, Air Business Ltd, c/o Worldnet www.bmj.com/subscriptions/vatandpaymentinfo.dtl Shipping Inc., 156-15, 146th Avenue, 2nd Floor, Jamaica, NY 11434, USA 000_EJHP0_EJHP TTOCOC & EEdd bboardoard ((19_02).indd19_02).indd 2 22/28/2012/28/2012 77:39:05:39:05 PPMM Editorial Special patients, specialised care Arnold G Vulto In most European countries, pharmacy An important feature of hospital pharmacy possibly also published studies, the situation students spend some time in hospital is the specialised pharmaceutical care we is not ideal. The reason is wider than just lack pharmacies to learn more about the different offer to sometimes very special patients that of knowledge. The current situation around forms of practice they can choose once may not be found in standard textbooks. clinical trials approval and drug legislation is qualified as a pharmacist. Also, in our It is therefore very timely that counterproductive to getting drugs researched pharmacy, we welcome several students the European Association of Hospital and licensed for small populations. Drug each year for an 8–10 week internship. Over Pharmacists (EAHP) has chosen ‘Special licensing is in the hands of a license holder, the years we have developed an intense Patient Groups – hospital pharmacists almost exclusively the pharmaceutical programme to show these students how creating standards of care’ as a theme for industry. Drug research and licensing is the theory of their studies is applied in the the 2012 annual congress. The congress very costly, and companies will look at cost practice of hospital pharmacy. At the end of programme highlights traditional special effectiveness before embarking on a clinical the internship we ask them to write a brief groups, such as children and geriatric study and applying for a license extension essay, answering four questions: patients but newer concepts will also be to smaller patient groups. I am curious what discussed. To mention just a few: care after kind of solutions the speakers of the seminar ▶ Describe the concepts behind the management of our hospital pharmacy transplantation, the limits of treatment, (Compassionate use and off-label medicines) compassionate drug use, the difficulties in will present for this dilemma. ▶ How can you justify the employment of 30 pharmacists (which to Dutch assessing the real value of new treatments An important new feature in our journal standards is quite high for a 1200 bed and the potential of genetic screening of is that all abstracts for poster and oral university hospital)? patients. Although we expect well above presentations that have been accepted by 2000 hospital pharmacists to participate the congress Scientific Committee will be ▶ Please provide some recommendations on how we can do a better job in the conference, the majority of EAHP published in EJHP. Hence these abstracts will members will be dependent on the journal be easily accessible for all members, and not ▶ Can you describe some essential differences between community to savour some of the highlights of the just those attending the congress.